[FDG-PET and CT in gastrointestinal stromal tumor treated with imatinib]

Ugeskr Laeger. 2003 Sep 8;165(37):3507-9.
[Article in Danish]

Abstract

The combined imaging modality PET/CT is a possible superior tool for evaluation of gastro-intestinal stromal tumor treatment illustrated in a case of a 59-year-old woman responding to imatinib.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Female
  • Fluorodeoxyglucose F18
  • Gastrointestinal Neoplasms / diagnostic imaging
  • Gastrointestinal Neoplasms / drug therapy*
  • Humans
  • Imatinib Mesylate
  • Middle Aged
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Radiopharmaceuticals
  • Stromal Cells* / pathology
  • Tomography, Emission-Computed
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Imatinib Mesylate